APTO's logo.
Ticker Symbol: APTO

Aptose Biosciences Inc

$2.76 - 22-07-2024 4 p.m. ET

Exchange: NASDAQ Country: Canada Currency: USD Asset Type: Common Stock CIK:0000882361

Company Profile

aptose biosciences is a science-driven biotechnology company advancing first-in-class agents to treat life-threatening cancers, such as acute myeloid leukemia (aml), high-risk myelodysplastic syndromes (mds) and other hematologic malignancies. based on insights into the genetic and epigenetic profiles of certain cancers and patient populations, aptose is building a pipeline of novel oncology therapies directed at dysregulated processes and signaling pathways. aptose is developing targeted medicines for precision treatment of these diseases, based on a patient’s specific gene expression signature. in the treatment of cancer, this strategy is intended to optimize efficacy and quality of life by minimizing the cytotoxic side effects associated with conventional therapies. cg026806 (cg’806) is a highly potent first-in-class pan-flt3/btk inhibitor. this small molecule therapeutic agent, exhibits a picomolar ic50 toward the fms-like tyrosine kinase 3 with the internal tandem duplication (flt

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 251 Consumers Rd Suite 1105
CEO: William Rice
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing


Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $2.27
Change: $0.11 ( 5.09%)
Days Range: $2.20 - $2.37
Beta: 0.79
52wk. High: $11.85
52wk. Low: $2.14
Ytd. Change -68.82%
50 Day Moving Average: $3.01
200 Day Moving Average: $5.08
Shares Outstanding: 7441267


Market Cap: 1.7B
PE Ratio: -
EPS (TTM): 0


Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A